DUBLIN, December 13, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/t2t8pl/global_anesthesia) has announced the addition of the "Global Anesthesia Drugs Market 2012-2016" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
TechNavio's analysts forecast the Global Anesthesia Drugs market to grow at a CAGR of 2.53 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in the number of emergency surgeries. The Global Anesthesia Drugs market has also been witnessing the pediatrics applications of anesthesia. However, the allergic reactions in anesthesia could pose a challenge to the growth of this market.
The key vendors dominating the Anesthesia Drugs market space are Abbott Laboratories, AstraZeneca PLC, and Baxter International Inc.
The other vendors mentioned in the report are Celgene Corporation, Claris Life Sciences, Eisai Co. Ltd., Endo Pharmaceuticals Inc., Halocarbon Products Corp., Hospira Inc., Merck and Co., Piramal Healthcare, and Roche Diagnostics.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Earlier, vendors manufactured gender-neutral anesthesia drugs. Nowadays, sex-based anesthesia drugs are being introduced into the market to address the concerns related to perioperative anesthetic care for both sexes. This trend has a strong impact on the market.''
According to the report, one of the main drivers in this market is the increasing aging population across the world. The aging population across the world is expected to increase massively by 2050. This increase in the aging population results in increased surgeries, which in turn leads to increased use of anesthesia drugs. Thus, the growing aging population across the world propels the growth of the Global Anesthesia Drugs market.
For more information visit http://www.researchandmarkets.com/research/t2t8pl/global_anesthesia
SOURCE Research and Markets